Vaxcyte, Inc. NASDAQ:PCVX

Founder-led company

Vaxcyte stock price today

$31.73
-49.23
-60.81%
Financial Health
0
1
2
3
4
5
6
7
8
9

Vaxcyte stock price monthly change

-1.72%
month

Vaxcyte stock price quarterly change

-1.72%
quarter

Vaxcyte stock price yearly change

+27.69%
year

Vaxcyte key metrics

Market Cap
10.81B
Enterprise value
1.43B
P/E
-10.05
EV/Sales
N/A
EV/EBITDA
-6.94
Price/Sales
N/A
Price/Book
2.35
PEG ratio
0.12
EPS
-4.36
Revenue
N/A
EBITDA
-406.5M
Income
-436.82M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Vaxcyte stock price history

Vaxcyte stock forecast

Vaxcyte financial statements

Average Price Target
Last Year

$137.44

Potential upside: 333.16%

Based on estimate of 5 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Vaxcyte, Inc. (NASDAQ:PCVX): Profit margin
Jun 2023 0 -68.33M
Sep 2023 0 -92.66M
Dec 2023 14.44M -180.80M -1251.56%
Mar 2024 0 -95.02M
Vaxcyte, Inc. (NASDAQ:PCVX): Debt to assets
Jun 2023 1502819000 69.44M 4.62%
Sep 2023 1496057000 93.34M 6.24%
Dec 2023 1407917000 167.44M 11.89%
Mar 2024 2091305000 107.32M 5.13%
Vaxcyte, Inc. (NASDAQ:PCVX): Cash Flow
Jun 2023 -62.74M -333.56M 546.96M
Sep 2023 -57.54M 22.28M 48.55M
Dec 2023 -128.81M -13.92M 2.73M
Mar 2024 -159.12M -451.07M 818.19M

Vaxcyte alternative data

Vaxcyte, Inc. (NASDAQ:PCVX): Employee count
Aug 2023 158
Sep 2023 158
Oct 2023 158
Nov 2023 158
Dec 2023 158
Jan 2024 158
Feb 2024 158
Mar 2024 254
Apr 2024 254
May 2024 254
Jun 2024 254
Jul 2024 254

Vaxcyte other data

51.85% -48.15%
of PCVX is owned by hedge funds
33.63M -47.90M
shares is hold by hedge funds

Vaxcyte, Inc. (NASDAQ:PCVX): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 53000
Mar 2024 0 41961
Apr 2024 0 30283
May 2024 0 30283
Jun 2024 0 48483
Jul 2024 0 12283
Oct 2024 0 109098
Nov 2024 0 38250
Dec 2024 0 30366
Transaction Date Insider Security Shares Price per share Total value Source
Sale
PICKERING GRANT director, officer.. Common Stock 961 $92.06 $88,470
Sale
PICKERING GRANT director, officer.. Common Stock 1,029 $92.03 $94,701
Sale
PICKERING GRANT director, officer.. Common Stock 376 $93.35 $35,099
Option
EYDELMAN MIKHAIL officer: SVP, GEN COUNSEL & COR..
Stock Option (right to buy) 5,000 $21.41 $107,050
Option
EYDELMAN MIKHAIL officer: SVP, GEN COUNSEL & COR..
Common Stock 5,000 $21.41 $107,050
Sale
EYDELMAN MIKHAIL officer: SVP, GEN COUNSEL & COR..
Common Stock 1,435 $90.16 $129,384
Sale
EYDELMAN MIKHAIL officer: SVP, GEN COUNSEL & COR..
Common Stock 3,177 $91.91 $292,004
Sale
EYDELMAN MIKHAIL officer: SVP, GEN COUNSEL & COR..
Common Stock 388 $92.9 $36,046
Sale
PICKERING GRANT director, officer.. Common Stock 11,349 $92.06 $1,044,789
Sale
PICKERING GRANT director, officer.. Common Stock 1,409 $93.06 $131,123
Insider Compensation
Mr. Grant E. Pickering (1968) Co-Founder, Chief Executive Officer & Director $750,920
Mr. James Wassil M.B.A., M.S. (1969) Chief Operating Officer
$651,060
Mr. Andrew L. Guggenhime M.B.A. (1968) Pres & Chief Financial Officer
$540,710
Thursday, 19 December 2024
globenewswire.com
Tuesday, 3 December 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Tuesday, 5 November 2024
globenewswire.com
Wednesday, 11 September 2024
globenewswire.com
Sunday, 8 September 2024
seekingalpha.com
Friday, 6 September 2024
globenewswire.com
seekingalpha.com
marketwatch.com
Thursday, 5 September 2024
reuters.com
Wednesday, 4 September 2024
globenewswire.com
zacks.com
Tuesday, 3 September 2024
globenewswire.com
schaeffersresearch.com
barrons.com
reuters.com
investors.com
marketwatch.com
globenewswire.com
Monday, 2 September 2024
globenewswire.com
Monday, 26 August 2024
prnewswire.com
Wednesday, 31 July 2024
zacks.com
Monday, 29 July 2024
zacks.com
Tuesday, 2 July 2024
globenewswire.com
Wednesday, 8 May 2024
globenewswire.com
Tuesday, 2 April 2024
GlobeNewsWire
Wednesday, 28 February 2024
Zacks Investment Research
Monday, 26 February 2024
Zacks Investment Research
Zacks Investment Research
Thursday, 15 February 2024
GlobeNewsWire
  • What's the price of Vaxcyte stock today?

    One share of Vaxcyte stock can currently be purchased for approximately $31.73.

  • When is Vaxcyte's next earnings date?

    Unfortunately, Vaxcyte's (PCVX) next earnings date is currently unknown.

  • Does Vaxcyte pay dividends?

    No, Vaxcyte does not pay dividends.

  • How much money does Vaxcyte make?

    Vaxcyte has a market capitalization of 10.81B.

  • What is Vaxcyte's stock symbol?

    Vaxcyte, Inc. is traded on the NASDAQ under the ticker symbol "PCVX".

  • What is Vaxcyte's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Vaxcyte?

    Shares of Vaxcyte can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Vaxcyte's key executives?

    Vaxcyte's management team includes the following people:

    • Mr. Grant E. Pickering Co-Founder, Chief Executive Officer & Director(age: 57, pay: $750,920)
    • Mr. James Wassil M.B.A., M.S. Chief Operating Officer(age: 56, pay: $651,060)
    • Mr. Andrew L. Guggenhime M.B.A. Pres & Chief Financial Officer(age: 57, pay: $540,710)
  • Is Vaxcyte founder-led company?

    Yes, Vaxcyte is a company led by its founder Mr. Grant E. Pickering.

  • How many employees does Vaxcyte have?

    As Jul 2024, Vaxcyte employs 254 workers.

  • When Vaxcyte went public?

    Vaxcyte, Inc. is publicly traded company for more then 5 years since IPO on 12 Jun 2020.

  • What is Vaxcyte's official website?

    The official website for Vaxcyte is vaxcyte.com.

  • Where are Vaxcyte's headquarters?

    Vaxcyte is headquartered at 825 Industrial Road, San Carlos, CA.

  • How can i contact Vaxcyte?

    Vaxcyte's mailing address is 825 Industrial Road, San Carlos, CA and company can be reached via phone at +65 08370111.

  • What is Vaxcyte stock forecast & price target?

    Based on 5 Wall Street analysts` predicted price targets for Vaxcyte in the last 12 months, the avarage price target is $137.44. The average price target represents a 333.16% change from the last price of $31.73.

Vaxcyte company profile:

Vaxcyte, Inc.

vaxcyte.com
Exchange:

NASDAQ

Full time employees:

254

Industry:

Biotechnology

Sector:

Healthcare

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

825 Industrial Road
San Carlos, CA 94070

CIK: 0001649094
ISIN: US92243G1085
CUSIP: 92243G108